Abstract
Background
In many malignancies including intrahepatic cholangiocarcinoma (iCCA), prognostic significance of host-related inflammatory / immunonutritional markers have attracted a lot of attention. However, it is unclear which is the strongest prognostic indicator for iCCA among these markers. The aim of this study was to firstly evaluate the prognostic utility of inflammatory / immunonutritional markers in resected iCCA patients using a multiple comparison in addition to a new marker, lymphocyte-to-C-reactive protein (CRP) score.
Methods
A total of sixty iCCA patients, who underwent surgical resection between October 2004 and April 2019, were enrolled in this study. Their clinical and pathological data were retrospectively assessed using univariate and multivariate analysis to determine prognostic predictors for disease specific survival (DSS). Moreover, these patients, who were divided into high and low groups based on lymphocyte-to-CRP score, were compared these survival outcomes using Kaplan-Meier analysis with a log-rank test.
Results
In multivariate analysis, the significant prognostic factors were preoperative lymphocyte-to-CRP score (p = 0.008), preoperative CRP-to-albumin ratio (CAR; p = 0.017), pathological T category (p = 0.003), and pathological vascular invasion (p < 0.001). Resected iCCA patients with a low lymphocyte-to-CRP score (score 0) had significant better prognosis than patients with a high score (score 1 or 2) (p = 0.016). Notably, the mortality of the high lymphocyte-to-CRP score group did not show statistically difference from the poor mortality of unresected iCCA patients (p = 0.204).
Conclusions
Preoperative lymphocyte-to-CRP score was the strongest prognostic indicator in iCCA patients with surgical resection. In these patients, early intervention with nutritional support should be considered prior to operation.
Publisher
Public Library of Science (PLoS)
Reference55 articles.
1. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?;YH Shaib;Journal of Hepatology,2004
2. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma;J Bridgewater;Journal of Hepatology. European Association for the Study of the Liver,2014
3. Mutational landscape of intrahepatic cholangiocarcinoma;S Zou;Nature Communications. Nature Publishing Group,2019
4. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma;MN Mavros;JAMA Surg. American Medical Association,2014
5. Inflammation as a tumor promoter in cancer induction;M Philip;Seminars in Cancer Biology,2004
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献